John Bencich
CIK: 0001477056
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AEON
AEON Biopharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Bencich John
Bencich John (SEC CIK 0001477056) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of AEON Biopharma, Inc. (AEON).
Signal8 holds 2 ownership filings by Bencich John (1 Form 3, 1 Form 4), filed on Apr 3, 2026. Those filings report 1 transaction, the latest on Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bencich John's filings is in IRVINE, CA.
Recent filings by Bencich John
- Apr 2, 2026: Grant or award of AEON shares (Form 4, code A).
Other insiders filing for AEON Biopharma, Inc. (AEON)
- LYNCH TIMOTHY P, 10% Owner
- Thunen Shelley B, Director
- PALMISANO ROBERT J, Director
- Forth Marc, Director
- FISCHER JOST, Director
- Carter Eric G, Director